AltMountain

OrbiMed Royalty Opportunities II, LP

New York, NY · CIK 1632107
Status: no Form D since Feb 2015. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

OrbiMed Royalty Opportunities II, LP is a private equity fund based in New York, New York. According to its most recent Form D, filed Feb 2, 2015, it has sold $900,000,000 of interests to 83 investors since its first sale in Jan 2015. The minimum investment it accepts from an outside investor is $750,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Sven Borho; Jonathan Silverstein; Carl Gordon.

Total raised
$900,000,000Cumulative sales reported on Form D
Investors
83
First sale
Jan 30, 2015
Minimum investment
$750,000
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Sven Borho; Jonathan Silverstein; Carl Gordon
Latest Form D
Feb 2, 2015

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​‌⁠

Questions about OrbiMed Royalty Opportunities II, LP

What is the minimum investment for OrbiMed Royalty Opportunities II, LP?

According to its latest Form D, filed Feb 2, 2015, the minimum investment OrbiMed Royalty Opportunities II, LP accepts from an outside investor is $750,000.

Who can invest in OrbiMed Royalty Opportunities II, LP?

OrbiMed Royalty Opportunities II, LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has OrbiMed Royalty Opportunities II, LP raised?

OrbiMed Royalty Opportunities II, LP reports $900,000,000 sold from 83 investors on its Form D filed Feb 2, 2015. This is cumulative sales since the offering began, not current assets or performance.

Where is OrbiMed Royalty Opportunities II, LP based?

OrbiMed Royalty Opportunities II, LP is based in New York, New York.

When did OrbiMed Royalty Opportunities II, LP launch?

OrbiMed Royalty Opportunities II, LP reports its first sale in Jan 2015.

Size compared with every private equity fund

Raised more than 94% of the 3,677 private equity funds based in New York, and more than 94% of all 8,983 that report sales.

Other funds with the same team

More private equity funds in New York

Similar-size private equity funds in New York

All private equity funds in New York